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Abstract 
Background: Costa Rica, like other developing countries, is experiencing an increasing burden of 
chronic conditions such as diabetes mellitus (DM), especially among its elderly population. This 
article has two goals: (I) to assess the level of metabolic control among the diabetic population age 
60 years old in Costa Rica, and (2) to test whether diabetic elderly patients of community health 
centers differ from patients in other health care settings in terms of the level of metabolic control. 
Methods: Data come from the project CRELES, a nationally representative study of people aged 
60 and over in Costa Rica. This article analyzes a subsample of 542 participants in CRELES with self-
reported diagnosis of diabetes mellitus. Odds ratios of poor levels of metabolic control at different 
health care settings are computed using logistic regressions. 
Results: Lack of metabolic control among elderly diabetic population in Costa Rica is described as 
follows: 37% have glycated hemoglobin 7%; 78% have systolic blood pressure > 130 mmHg 66% 
have diastolic blood pressure 80 mmHg; 48% have triglycerides 150 mg/d1; 78% have LDL 100 
mg/di; 70% have HDL 40 mgldl. Elevated levels of triglycerides and LDL were higher in patients 
of community health centers than in patients of other clinical settings. There were no statistical 
differences in the other metabolic control indicators across health care settings. 
Conclusion: Levels of metabolic control among elderly population with DM in Costa Rica are not 
that different from those observed in industrialized countries. Elevated levels of triglycerides and 
LDL at community health centers may indicate problems of dyslipidemia treatment among diabetic 
patients; these problems are not observed in other health care settings. The Costa Rican health 
care system should address this problem, given that community health centers constitute a means 
of democratizing access to primary health care to underserved and poor areas. 
Background 
Several Latin American countries are advancing quickly 
through the epidemiologic transition. They are facing a 
double epidemiologic burden, since the prevalence of  
chronic illnesses is increasing and some infectious dis-
eases have not been completely eradicated [1-31. Costa 
Rica, one of the Latin American leaders in the epidemio-
logic transition, achieved a very fast reduction in the prey- 
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alence of communicable diseases and malnutrition 
thanks to improved access to primary health care [4]. 
However, this primary health care system is now strug-
gling with an increase in the aged population and in the 
burden of chronic and degenerative diseases [2-5]. Adap-
tation to this new epidemiological profile may be harder 
in developing countries than in the industrialized world 
because of the great speed of changes and the relative scar-
city of economic resources of the population and of the 
providers. 
Diabetes mellitus (DM) is one of the illnesses with the 
highest burden among Latin American elderly because 
survivors of the cohorts born during the first half of the 
20th century may be adopting nutritional and lifestyle 
behaviors of the industrialized world [3,5-7], and at the 
same time these cohorts experienced disadvantaged 
health conditions during their younger years [3,8]. These 
two circumstances are argued to be risk factors for the 
development of DM [3]. In Costa Rica, the country with 
the highest life expectancy in Latin America [4], death 
rates due to DM in 2004 are 2.5 times the rates observed 
in 1990 [9]. The prevalence of diabetes in 2000 among 
people 20 years and above was 3.3% in Costa Rica, 
according to official figures of the World Health Organi-
zation (WHO) [10]. It is also the illness with the highest 
total hospitalization cost, and the second in outpatient 
costs (after hypertension) for the Costa Rican public hos-
pital and clinic system [11]. Adequate management of 
DM is becoming an important public health concern in a 
country whose health care system needs to face the chal-
lenge of an increasing burden of chronic diseases. 
Studying the burden of chronic diseases in Costa Rica is 
also becoming important because of its demographic con-
text. The population is aging at a rapid pace. The popula-
tion age 60 and over will triple from 2000 to 2025, and its 
share among the total population will increase from 8% 
to 16%. Costa Rica is also one of the Latin American coun-
tries with the highest proportion of the elderly living in 
rural areas (37%). Regarding ancestry, most Costa Rican 
elderly can be classified as of "mixed ethnic origins", 
descendants of a combination of ethnic backgrounds: 
Europeans, indigenous groups, African blacks, and Chi-
nese immigrants. However, Costa Ricans see themselves 
as "white' or "mestizo". Around 1% of the people age 60 
and above classifies themselves as indigenous and less 
than 2% as blacks, and these minorities are dispropor-
tionately located in the province of Limon, in the Carib-
bean coast. An important proportion of the black 
community in Costa Rica descends from immigrants who 
came to work on the railroad from Jamaica and Barbados 
during the late part of the 19th century. From a demo-
graphic perspective, country of origin is more relevant  
than race, given that 8% of the elderly population was 
born abroad, especially in Nicaragua [9]. 
Although Costa Rica has a mixed health care system, most 
of the services are provided through a network of hospi-
tals and clinics managed by a public institution-the Social 
Security system. This system is in part responsible for the 
high life expectancy levels of Costa Rica [12,13]. The 
Social Security system is funded from deductions from the 
payroll, and contributions by the employers and the Gov-
ernment. This is the so-called "contribution regime". 
Workers that contribute to the System are entitled to 
health insurance that allows them and their family to 
receive free health care services and free medications at 
any hospital, clinic or community health center run by the 
Social Security system. Additionally, after a 'means test", 
the Government provides health insurance to poor people 
who are not entitled to it through the "contribution 
regime'. This is the so-called "insurance by the State" or 
the "non-contribution" regime. Data from the CRELES 
sample show that the contribution regime covers around 
80%; the non-contribution, 15%; and 5% are not insured. 
There are no copayments for receiving health care. Finally, 
there are also private hospitals, clinics, and physician 
offices. People who seek services at these private health 
care settings have to pay out-of-pocket not only for health 
care but also for medication and laboratory tests. A new 
market of private health insurance that caters to high 
income families is starting to grow in Costa Rica. Interest-
ingly, there are people who use both sectors (e.g., people 
go for outpatient visits at public clinics but pay out-of-
pocket for laboratory examination at private laboratories) 
114 It is important to say also that most of the private 
hospitals and clinics are located in the Metropolitan Area, 
where the capital is, while community health centers, and 
public clinics and hospitals are spread over the Costa 
Rican territory. 
A recent health sector reform, that started around 1995, 
achieved further advances in reducing child and adult 
mortality 1131. One of the key elements of the reform was 
the establishment of community health care centers, 
called EBAIS (abbreviation in Spanish for "Basic Inte-
grated Health Care Teams"), in different urban and rural 
settings. The area covered by each EBAIS has an average 
population of 2,500 to 7,000 inhabitants. These commu-
nity health centers are staffed with at least a physician, a 
nurse, and a community health worker; several EBAIS may 
receive also professional support from an additional team 
composed of another physician, another nurse, a social 
worker, a dentist, a nutritionist, a pharmacist, a micro-
biologist, and a medical records technician [14]. 
The opening of EHAIS allowed the Government to reor-
ganize the structure of the public health care system. The 
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community health centers are a key component in 
improving access to primary health care services, since 
they were first established to serve patients living in rural 
areas or in poor neighborhoods [13,14]. These commu-
nity health centers provide outpatient services (preventive 
services and health promotion), while clinics and hospi-
tals provide primary, secondary and tertiary health care, 
although they are specialized on the last two types of care: 
inpatient and more specialized outpatient health care 
(like surgeries, cancer treatment, intensive care units, or 
emergencies). Community health centers seek to rational-
ize resource allocation by referring only those patients 
who need specialized treatment to specialists in clinics 
and hospitals. In this sense, they serve as "gate-keepers" 
for the whole public system. In the past, outpatient visits 
for chronic disease control were held only in clinics and 
hospitals. Nowadays, EBAIS have also assumed this kind 
of consultations as part of their mission of delivering pre-
ventive services [14]. 
Private health care providers deliver the same health care 
services as the public system, although there is no integra-
tion among providers of primary, secondary, and tertiary 
health care. Besides, private health care services are not 
organized into health care management programs. Diabe-
tes education and community preventive programs are 
rare in the private sector, and this is a major difference 
between both types of providers. The other major differ-
ence is the existence of waiting lists in the public system. 
While patients at public clinical settings have to wait as 
much as several months (or even years) for an appoint-
ment (especially if the appointment is aimed for routine 
check-ups or laboratory exams), services at private settings 
are more timely and readily available [14]. Still, a Costa 
Rican who receives health services at public health centers 
has gone on average 5.4 times per year to outpatient serv-
ices, but Costa Ricans that receive services at the private 
sector have gone on average 3.8 times per year to outpa-
tient visits. The difference is greater among people who 
have been hospitalized. Among them, the average number 
of days stayed at a public hospital is 12.6 days and, at a 
private hospital, it is 5.6 days [15]. In general, access and 
coverage in the private sector can not be compared to 
access and coverage in the public sector, since the services 
of the latter are basically free to all affiliates but affected 
by long waiting lists, while access and coverage in the pri-
vate sector depend entirely on purchasing power. 
Even though achievements of the Costa Rican health sec-
tor reform (which has not yet finished) have been docu-
mented [12-14,16], chronic disease management for 
elderly patients has proved difficult for the public health 
care system. The system has very high coverage in services 
aimed to pre-natal care and children (e.g., OPT vaccina-
tion = 90%, births delivered in the public system that had  
http://www. biomedeentra 1. mm/1472-698X/815 
pre-natal care = 93%), but only 57% of the elderly popu-
lation and 84% of the total population with DM received 
some kind of treatment at any of the public system's pri-
mary health care facilities during 2005 114 
A way of exploring how well community health centers 
are carrying out the task of providing DM-related preven-
tive services to the elderly is by comparing levels of meta-
bolic control across health care settings. As previously 
explained, public hospitals and clinics provide outpatient 
services, but they are aimed to treat cases that need more 
specialized treatment, while EBAIS are supposed to work 
as "gate-keepers" providing basic primary health care to 
patients, before they are remitted to specialists. Patients 
that receive outpatient services at public hospitals and 
clinics are expected to be a selected population that needs 
specialized treatment. A working hypothesis is that, under 
the current health care system in Costa Rica, patients 
whose last outpatient visit was at an EBAIS have metabolic 
control at least as good as patients who had their last out-
patient visit at a secondary or tertiary level service (hospi-
tals and clinics). If metabolic control is inferior among 
community health center patients than among hospital or 
clinic patients, then this can be interpreted as evidence of 
limitations in chronic disease management in the public 
primary health care system. 
This article has two goals. The first is to assess the level of 
metabolic control among the diabetic elderly population 
in Costa Rica, following the standards proposed by the 
American Diabetes Association (ADA) 1171. This goal is 
important for the Costa Rican and Latin American context 
because there is very little research in the region that meas-
ures metabolic control in a nationally representative sam-
ple of the diabetic population. The second is to test 
whether diabetic elderly patients of community health 
centers have elevated levels of metabolic control that are 
different from levels of patients from other health care set-
tings in Costa Rica. Metabolic control among diabetic 
patients is then utilized as an indicator of the efficacy of 
treatment that the physician prescribes to the patients 
[17]. The results regarding the second goal will shed light 
on whether the health sector reform is adequately 
responding to the increasing burden of highly prevalent 
chronic diseases among the elderly population. 
Methods 
Data collection 
The Costa Rican Study on Longevity and Healthy Aging 
(CRELES, for its name in Spanish) is an on-going longitu-
dinal study of a nationally representative sample of 2,827 
adults born in 1945 or before (ages 60 and over at the first 
interview) and residing in Costa Rica in the year 2000. The 
data used in this article refer to the first wave of interviews, 
conducted from November 2004 through September 
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2006. This sample size was obtained from a two-step pro-
cedure. First, an original sample of 9,600 individuals was 
randomly selected from the 2000 census database with 
stratification by 5-year age groups, with oversampling of 
older individuals. Sampling fractions ranged from 1,1% 
among those born in 1941-45 to 100% for those born 
before 1905. In a second step, an in-depth longitudinal 
study was carried out in a sub-sample of 60 "health areas' 
(out of 102 for the whole country), selected from the 
"mother sample" with probability proportional to the 
population ages 60 and over. This sub-sample included 
near 4,700 individuals. The sub-sample, which covers 
59% of Costa Rican territory, yielded the following non-
response rates: 19% deceased by the contact date, 18% 
not found in the field, 2% moved to other addresses, 2% 
declined to be interviewed, 2% pendant interviews after 
several visits (likely rejections). After all these types of 
non-response are taken into account, the final sample is 
2,827 participants. From those interviewed: 95% pro-
vided blood sample, 91% had anthropometric measures, 
and 24% required a proxy to answer the questionnaire. 
The in-depth interview addresses topics such as: self-
reported health status, functional limitations, household 
characteristics, utilization of health care services, insur-
ance and working status, inter-generational transfers, and 
demographic characteristics. All data and specimens in 
the study were collected at the participants' homes, usu-
ally during two visits, using Personal Digital Assistants 
(PDAs), also known as palm computers, with software 
applications developed by Centro Centroamericano de Pob-
laden (CCP) for this study. In the first visit, participants 
provided informed consent for the interview and 
answered a 90-minute long questionnaire (including 
some mobility tests and two blood-pressure measures) as 
well as a 10-minute food frequency questionnaire to trace 
the intake of specific nutrients. The interviewer also asked 
permission to check all medication prescribed by a health 
care professional. In a second visit early the next day, fast-
ing blood samples were collected by venipuncture: 1 
EDTA purple top tube (for 3-4 ml. of whole blood) and 2 
serum separating tubes (SST) with a clot activator (for 10-
12 ml. of blood, to obtain 4-6 ml. of serum). Specimens 
were analyzed in several laboratories according to the 
methods described elsewhere [18]. Linear adjustments 
were performed to have comparable measurements across 
laboratories; technical support for the adequacy of these 
linear adjustments was provided by microbiologists. LDL 
levels were computed using the Friedewald equation [19]. 
DBP and SBP were computed as the mean of two inde-
pendent measurements of blood pressure taken during 
the interview at rest position, with a planned interval of 
20 minutes from one another. 
http://www.biomedcentral.com/1472-698X/8/5  
Population and dependent variable definition 
The subclass of elderly patients with DM is defined as 
respondents that answer yes to the question: "Has a doc-
tor or medical personnel ever told you that you have dia-
betes or high blood sugar levels?" With this question, it is 
impossible to determine whether the patients have Type I 
or Type II DM. However, all respondents were diagnosed 
after age 30, and have survived until at least age 60; there-
fore, it is likely that most if not all of them have Type II 
DM. The size of the subsample based on the answer to the 
above question is 542 individuals, 503 of them with 
blood sample and valid data for assessing their metabolic 
control. Since this paper focuses only on people diag-
nosed with DM, the analyses in this article are performed 
on this subsample. 
Metabolic control is studied by recording levels in gly-
cated hemoglobin (HbAic), diastolic and systolic blood 
pressure (DBP and SBP), low-density lipoprotein (LDL) 
cholesterol, high-density lipoprotein (HDL) cholesterol, 
and triglycerides. Elevated levels of each biomarker are 
defined according to the standards recommended by the 
ADA; therefore, elevated levels are: HbA, 	 7%, DBP 
130 mmHg, SBP z 80 mmHg, LDL z 100 mg/dl, HDL 40 
mg/dl, and triglycerides 150 mg/c11. High blood pressure 
is defined when DBP 130 mmHg and SBP z 80 mmHg 
[17]. 
Three more response variables that refer to preventive 
practices are analyzed: regular aspirin intake, having been 
vaccinated against influenza during the last year, and hav-
ing visited a physician at least once in the past year for DM 
control. Information for these variables is taken from 
direct answers to questions in the survey instrument. Pro-
portions calculated from the two response variables just 
listed above are considered as indicators of problems in 
DM quality care, based on standards of the National Dia-
betes Quality Improvement Alliance measurement set 
[20]. 
independent variable definition 
The main independent variable is derived from self-
reported answers to the question: "Where did you have 
your last outpatient visit?" Since very few observations 
were in the categories "private hospital", "private clinic", 
and 'private physician office", these were merged into the 
single category "private clinical setting." 
Potentially confounding variables are derived also from 
direct answers to the questionnaire by respondents or 
their proxy respondents: sex, age, income, years of educa-
tion, region of residence, having health insurance, history 
of stroke, history of heart attack, smoking, and years since 
DM diagnosis. Obesity, another potential confounder, is 
defined as having a body mass index (BMI) higher than 
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30. BMI was estimated using information on weight in kil-
ograms (kg) divided by height squared in squared meters 
(m2). Weight and height were measured by the interview-
ers usually during the second visit with an estadiometer 
(214 Seca Road Rod, Quickmedical) for height and a scale 
(LifeFource, model UC321P, A&D medical) for weight 
brought by the interviewer. Standard procedures are used 
by every interviewer to minimize or avoid measurement 
bias. Analyses also control for caloric intake, which is esti-
mated from answers to a questionnaire on frequency of 
consumption of about 30 food-tracer items. 
Statistical analysis 
Statistical analysis is conducted using STATA SE version 
9.0 (Stata Corporation, 2006). Descriptive statistics 
include proportions for categorical variables, and means 
and standard deviations for continuous variables. Ninety-
five percent confidence intervals are reported for univari-
ate descriptive statistics. Using logistic regressions to con-
trol for confounders, the effect of health care settings on 
metabolic control are analyzed computing odds ratios. All 
statistical analyses take into account differential sampling 
weights. 
Ethics clearance 
The University of Costa Rica Ethics Committee approved 
the procedure for collecting data and the informed con-
sent form. Institutional Review Boards at the University of 
California-Berkeley and at the University of Wisconsin-
Madison reviewed the approval so members of these Uni-
versities could participate in the project. 
Results 
Descriptives 
Metabolic control may depend not only on health seeking 
behaviors and treatment compliance by diabetic patients, 
but also on DM risk factors. According to Table 1, the dia-
betic population age 60 and above in Costa Rica has a rel-
atively low prevalence of some of these risk factors. 
Obesity among Costa Rican elderly with DM is around 
34%; merely 6% are currently smoking. Only 6% have 
had a stroke before the interview, and 8% have had a heart 
attack. Regarding characteristics related with access to 
health care services, health insurance coverage is almost 
universal for the Costa Rican elderly: 96% report having 
health insurance. This high health insurance coverage 
contrasts with the low socio-economic status (SES) that 
these cohorts have, given that more than half of older per-
sons in Costa Rica have less than 6 years of education and 
more than a third of this population have a monthly 
income of $100 or less (its own if not married, or the aver-
age of the couple's monthly income if married). 
As mentioned before, health care in Costa Rica is provided 
predominantly by the public network of hospitals, clinics,  
http://www.biomedeentral.com/1472-698X/8/5  
Table I: Characteristics of the diabetic population age 
Costa Rica, 2004-2006. (n = 542) 
60, 
Characteristics 
Prevalence of self-reported DM diagnosis 20.8 
% Females 61.2 
% age 60-69 y.o. 54.0 
% age 70-79 y.o. 35.8 
% age 2 80 y.o. 10.3 
w16 years or more of schooling 46.8 
w/couple's or individual's income < $100 per month 35.4 
% living in Metropolitan capital city 54.0 
w/health insurance 95.7 
% w/history of stroke 5.7 
w/history of heart attack 7.9 
% wlbody mass index (BMI) ?: 30 Kg/m2 33.6 
% currently smoking 6.1 
% w/oral medication for DM 69.4 
% w/insulin injections 31.0 
% diagnosed 0-4 years ago 32.5 
% diagnosed 5-9 years 18.2 
% diagnosed 10 or more years 47.3 
% with year of diagnosis unknown 2.0 
and community health centers. As illustrated in Table 2, 
81% of the diabetic population report having their last 
outpatient visit at a public health care setting. Addition-
ally, although 4% of elderly diabetic patients report to 
have their last outpatient visit at home, it is very likely that 
some of them were attended by health professionals from 
EBAIS, as part of their community home visits. 
Levels of metabolic control 
Mean levels of biomarkers used as indicators of metabolic 
control are very close to the endpoints defined as stand-
ards by the ADA, which signals that an important propor-
tion of the diabetic elderly population in Costa Rica is not 
having proper metabolic control. As seen from Table 3, 
glycemic control, as measured by HI3A,c levels, seems to 
be inadequate among 37% of the diabetic elderly. Most 
also have elevated blood pressure levels. Also indicating 
high risk, 78% have LDL cholesterol levels above or equal 
to 100 mg/dl, and 70% have HDL cholesterol levels below 
Table 2: Place of last outpatient visit among diabetic population 
age 60 in Costa Rica, 2004-2006 (n = 542). 
Total 100.0 
Public hospital 23.8 
Public clinic 23.8 
EBAIS 33.4 
Private hospital, clinic or physician office 13.2 
Patient's home 4.0 
Other 1.6 
Unknown 0.2 
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or equal to 40 mg/dl. The proportion with elevated triglyc-
eride levels (48%) is slightly lower. 
Regarding preventive behaviors, more than half of the dia-
betic elderly in Costa Rica are taking aspirin to prevent 
cardiovascular events, and also less than half were vacci-
nated against influenza during the last year. There seems 
to be close contact between diabetic patients and their 
physicians, given that only 10% lack a diabetes-related 
examination by their physician at least once a year. Note 
that sample sizes are uneven across metabolic control 
indicators, because there were some blood specimens 
with problems for computing levels of HbAic, Triglycer-
dies, LDL, and HDL. 
Variation in the standards for HbA1C 
Given that the target population in this analysis is com-
prised of elderly Costa Ricans with DM, it is important to 
acknowledge that ADA standards might be too strict or 
aggressive as clinical goals, that higher levels of HbAl C 
and blood pressure might not be harmful and might even 
be beneficial for elderly diabetic patients, and that reduc-
tion in these biomarker levels might be more important in 
improving a patient's health than just the absolute target 
121-25]. Raising the cutoff points diminishes the preva-
lence of poor control considerably Table (4). If HbAic  
9% defines poor glycemic control, instead of HbAlc 7%, 
prevalence of poor glycemic control decreases in more 
Table 4: Proportion with poor levels in metabolic control, by 
age, using different endpoints. 
Metabolic control indicators Age 
Total 60-74 75 or more 
HbAlc 
z_ 7% 36.9 39.4 28.9 
z8% 21.8 24.0 15.1 
> 9% 14.8 17.0 7.8 
SBP 
130 mmHg 78.2 77.6 79.9 
140 mmHg 62.2 61.1 65.7 
150 mmHg 41.8 41.1 44.0 
DBP 
80 mmHg 65.9 69.4 55.1 
85 mmHg 50.9 54.2 40.8 
90 mmHg 33.0 36.4 22.6 
than half (15% vs 37%). Similar reductions are observed 
if elevated SBP is defined as SBP 150 mmHg instead of 
SBP 2 130 mmHg (42% vs. 78%), and if DBP is defined as 
DBP > 90 mmHg instead of DBP 80 mmHg (33% vs. 
66%). The proportion of diabetic elderly with elevated 
HhA,c and DBP levels is significantly lower (p < 0.05) 
among people age 75 or more than among people ages 60 
to 74. These figures match with previous conclusions that 
Table 3: Levels of metabolic control biomarkers for diabetic population age z 60, Costa Rica, 2004-2006. 
Metabolic control indicators (n) 95% CI 
Mean (SD) 
HbAric (%) 503 7.0 (1.8) (6.8- 	 7.2) 
SBP' (mmHg) 539 148.2 (23.4) (146.0- 	 150.4) 
DBP' {mmHg) 539 84.6 (12.4) (83.4- 	 85.8) 
Triglycerides (mg/di) 516 179.9 (110.0) (169.4- 	 190.4) 
LDL (mg/di) 463 131.1 (39.5) (126.8- 	 135.4) 
HDL (mg/d1) 516 41.2 (11.7) (40.0- 	 42.4) 
(%) 
HbA,e 2 7% 503 36.9 (31.8- 	 41.9) 
HbAic 2. 6.5% 503 52.1 (46.9- 	 57.3) 
SBP 	 130 mmHg' 539 78.2 (74.0- 	 82.4) 
DBP 	 80 mmHga 539 65.9 (61.2- 	 70.6) 
SBP z  130 mmHg & DBP .130 mmHg' 539 61.7 (56.8- 	 66.5) 
Triglycerides z 150 mgldl 495 47.5 (42.3- 	 52.8) 
LDL > 100 mgldl 463 78.3 (73.8- 	 82.8) 
HDL 	 40 mg/d1 516 70.2 (65.5- 	 75.0) 
Without aspirin intake 525 39.9 (34.9- 	 44.8) 
Without influenza vaccine last year 537 45.9 (40.8- 	 51.0) 
Without physician examination at least once a year 537 10.2 (7.1- 	 13.3) 
Note: a/Arithmetic mean of two measurements 
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most diabetic elderly in Costa Rica have adequate glyc-
emic control, but are very likely to have high blood pres-
sure levels. Multivariate models in the next section are 
also estimated using these different cutoff points, but 
results are not presented in tables unless the conclusions 
are different from analyses using ADA standards. 
We do not present analyses with different endpoints for 
lipid control because the ADA standards are also recom-
mended by the National Cholesterol Education Program 
Adult Treatment Panel III 1261, given that older persons 
with DM are considered at high risk of cardiovascular dis-
ease. Therefore, ADA standards are not considered as too 
aggressive. 
Differences in metabolic control across health care 
settings 
In bivariate analyses that do not control for confounders, 
based on )(2 likelihood-ratio tests of homogeneity, differ-
ent health care settings show significant differences in just 
two control indicators: triglycerides (p < 0.01) and lack of 
annual physician examination (p < 0.10) (Table 5). 
Regarding the latter condition, patients that had their last 
outpatient visit at a private clinical setting or at their own 
home are less likely to have such periodic visits. However, 
in terms of triglyceride control, elderly patients who had 
their last visit at a community health center or at home are 
more likely to have triglycerides z 150 mg/dl. The differ-
ence is observed even among patients with prescribed  
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HMG-CoA reductase inhibitors (statins, the most com-
mon medication for lipid control observed in the sam-
ple). This result contrasts with what is observed with 
HbAic, hypertension, HDL, or LDL control, since propor-
tions with poor levels in these biomarkers are very similar 
across health care settings with no statistically significant 
differences. The absence of significant differences persists 
even after observing patients with different patterns of 
treatment, as observed in Table 5, among people pre-
scribed with insulin, with oral hypoglycemic medication, 
or with antihypertensive medication. 
In order to test whether there is confounding effect in 
these bivariate relationships, one logistic regression for 
each metabolic control indicator was estimated. Patients 
who had their last outpatient visit at home are excluded 
from the analyses because their corresponding sample 
size is very small (20 persons or less, depending on the 
indicator). Odds ratios for poor metabolic control levels 
estimated with the regression models are net of the effect 
of the characteristics described in Table 1. Controlling for 
age-one of the variables in the analysis-is important 
because clinical goals for metabolic control can vary 
according to patients' age. 
Results, shown in Table 6, confirm what was observed pre-
viously. There are no significant differences in the preva-
lence of poor levels of HbAic, SBP, DBP, BP, and HDL, at 
the community health center when compared to the other 
Table 5: Proportion with poor levels in metabolic control, by place of last outpatient visit 
Metabolic control indicators Public hospital (%) Public clinic (%) Comm. health centers (%) Private clinical setting (%) Patient's home (%) 	 x2 p-value 
HbAic 	 7% 36.5 33,6 38.4 43.0 28.9 
-People with insulin (n = 154) 53.3 47.4 68.6 54.5 42.3 
-People with oral medication (n = 346) 38.5 29.3 35.9 47.0 32.0 
SBP 2 130 mmHg' 82.7 74.8 78.3 80.2 68.5 
-People with antihypertensive medication 
(n = 358) 
81.1 73.2 84.3 75.3 72.0 
DBP z 80 mmHg' 66.2 66.1 66.0 70.0 50.0 
-People with antihypertensive medication 
(n = 358) 
63.4 60.3 66.8 74.1 52.1 
SBP z 130 & DBP 2 80 mmHg. 64.4 63.3 60.1 62.1 48.8 
-People with antihypertensive medication 
(n = 358) 
61.8 58.8 65.2 65.9 52.1 
Triglycerides 2 150 mgldl 42.5 39.9 56.6 33.6 63.6 	 4.11c 
-People with statin medication (n = 126) 49.6 40.3 71.3 32.0 73.6 
LDL 	 100 ing(di 72.7 79.9 84.0 66.8 70.1 
-People with statin medication (n = 112) 77.7 79.8 84.3 47.7 84.4 
HDL . 40 medl 68.9 75.6 70.1 62.4 62.9 
Without aspirin intake 33.9 43.9 39.1 4.6.6 35.8 
Without influenza vaccine last year 43.0 49.1 42.7 59.7 40.8 
Without physician examination at least 
once a year 
13.3 5.6 8.4 19.5 19.4 	 * 
Notes: *: p < 0.10, **: p < 0.05.***: p < 0.01 
a/Arithmetic mean of two measurements 
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Table 6: Odds ratios for poor levels of metabolic control by place of last outpatient visit. 
Metabolic control indicators {n) Community health centers Public clinic Public hospital Private clinical setting 
HbAic L. 7% 460 1.00 0.93 0.84 1.40 
-People with insulin 134 1.00 0.32 * 0.34 * 0.25 
-People with oral medication 321 L00 0.75 1.14 2.03 
SBP a. 130 mg/dlb 479 L00 0.82 1.28 1.22 
-People with antihypertensive medication 321 1.00 0.51 0.80 0.43 
DBP > 80 mg/dlb 479 1.00 1.21 1.11 L65 
-People with antihypertensive medication 321 1.00 0.83 1.02 1.47 
513P 	 130 & DBP 	 80 mmHgb 479 1.00 1.34 1.33 1.30 
-People with antihypertensive medication 321 1.00 0.86 1.01 1.02 
Triglycerides> 150 mg/d1 452 1.00 0.51 ** 0.63 0.40 ** 
-People with statin medication 99 1.00 0.38 0.32 0.17 * 
LDL z 100 mg/dl 423 1.00 0.72 0.40 " 0.27 *4* 
-People with statin medication 76 1.00 0.15 0.20 0.01 *** 
HDL 540 mg/dl 472 1.00 1.63 1.17 0.85 
Without aspirin intake 471 1.00 1.05 0.80 1.10 
Without influenza vaccine last year 478 1.00 1.40 1.17 1.62 
Without physician examination at least once a year 478 1.00 0.95 1.09 7.10 ** 
Notes: a/Odds ratios computed from logistic regressions that control for sex, age, income, schooling, region of residence, health insurance, history 
of stroke, history of heart attack, smoking, obesity, and years since diagnosis of DM. The odds ratios for biomarkers are also controlled for 
estimated caloric intake. Analyses exclude interviewees who had their last outpatient visit at home, because sample size for that category is too 
small. 
b/Arithmetic mean of two measurements 
health care settings. Results are robust to different patterns 
of medication therapy, although poor glycemic control is 
higher in community health center patients than in public 
clinics and hospitals, when only patients treated with 
insulin are analyzed (p < 0.10). Elderly diabetic patients 
treated at public clinics (but not at public hospitals) and 
at private clinical settings are less likely to have triglycer-
ides > 150 mg/dl, than patients treated at community 
health centers. The multivariate analyses also show that 
poor levels of LDL cholesterol are also less common 
among patients of public hospitals and private outpatient 
services, than at community health centers. These differ-
ences across health care settings seem to be larger when 
only patients with prescribed statin medication are 
observed, although the sample size is too small to have an 
acceptable level of statistical power (more than 80%). 
Interestingly, among people that visit private clinical set-
tings, frequency of having a DM related examination by a 
physician seems to be inadequate since they do not report 
to have at least one physician examination per year. 
Another conclusion drawn from the multivariate models 
(results not shown in the tables) is that DM duration is 
associated only with elevated levels of HbAic and lack of 
physician examination during the last 12 months. People  
who were diagnosed more than 4 years ago are twice as 
likely to have HbAic 7% as people with more recent 
diagnosis. On the other hand, patients with more recent 
diagnosis are also more likely to lack a DM-related physi-
cian examination during the last 12 months. Whether this 
latter finding is due to the problem of waiting lists in the 
public health care system is not clear. 
Why are community health centers having higher propor-
tions of diabetic elderly patients with high triglycerides 
and LDL levels? The survey instrument has questions 
about when was the last time respondents have their cho-
lesterol levels measured. Besides, as mentioned before, 
the questionnaire recorded all prescribed medication that 
respondents were taking. We thus have data to test 
whether elevated levels in triglycerides and LDL in EBAIS 
patients come from lack of periodic cholesterol examina-
tion, from differences in type of medication, or from both 
(Table 7). There are statistically significant differences in 
the proportions of diabetic elderly patients having their 
last cholesterol level measured during the last 6 months 
across health care settings (x2 likelihood-ratio homogene-
ity test, p < 0.05). However, people who attended corn mu-
nity health centers are more likely to have this test, 
especially when compared to people at private clinical set- 
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Table 7: Proportion reporting cholesterol treatment, by place of last outpatient visit 
Lipid control indicators 	 Public hospital 	 Public clinic 
	 Community health center 	 Private clinical setting y2 p-value 
Cholesterol test in last 6 months 	 86.8 	 88.6 
	
94.9 
	
77.7 
Statin medication (current use) 
	
20.1 	 22.8 
	
24.1 	 28.8 
Notes: *: p < 0.10, ": p < 0.05.'x*: p < 0.0I 
zings. Finally, there are no statistical differences in the pro-
portions having HMG-CoA reductase inhibitors (statin) 
medication. Adding these variables in the logistic regres-
sions does not modify the size of the estimated odds ratios 
reported before; estimating models with other nutritional 
variables, such as carbohydrate intake or fat consumption 
or oil used for cooking, or accounting for hypertensive 
medication (which can alter lipids laboratory results) do 
not change the size of the odds ratios either (results not 
shown). Therefore, higher prevalence of elevated triglycer-
ide and LDL levels among community health center 
patients does not seem to be explained by differences in 
medication or in frequency of periodic cholesterol-related 
examination. Given that estimated logistic regressions 
control for caloric intake, smoking, age, sex, obesity, 
region of residence, education, income, and DM medica-
tion (insulin and oral medication intake), it is unlikely 
that differences in distributions of this kind of character-
istics are the ones that are explaining the association 
between triglyceride and LDL levels, and health care set-
tings. 
Given the concern posed above about how ADA standards 
might be too burdensome or strict as clinical goals for dia-
betic older patients, the logistic models of this section are 
also estimated using the different cutoff points shown in 
Table 3 for HbAtc, SBP, and DBP. Compared to the origi-
nal models with ADA standards, the size of the odds ratios 
change, but the same conclusions are drawn: there are no 
differences in the prevalence of poor levels of HbAic, SBP, 
and DBP across health care settings (results are not pre-
sented but can be provided upon request). 
Discussion 
The first goal of this article was to assess the levels of met-
abolic control among elderly diabetic population in Costa 
Rica, using the guidelines of the ADA as a point of com-
parison 117]. Mean levels of HbA, c, HDL, and LDL, and 
the proportion of patients having elevated levels in the 
same biomarkers, seem high in a first look. However, 
these are similar or even lower than those reported in 
high-income populations in the U.S. [20,27-31], Ger-
many [32], Sweden 1331, and France [34]. Elevated levels 
of DBP and SBP are considerably higher than in the U.S., 
while mean levels of triglycerides are lower [20]. When 
compared to another developing country, prevalence of 
poor levels of HbAic, DBP, triglycerides, and LDL are  
lower in this Costa Rican population than in a slightly 
younger population in Medellin, Colombia; only the pro-
portion of HDL 40 mg/dl was higher in Costa Rica than 
in Medellin [35]. Preventive health behaviors are broadly 
practiced among the Costa Rican older population with 
DM: only 40% is not having aspirin therapy regularly, and 
46% report not to have an influenza vaccine during the 
last 12 months. Additionally, only 10% report not to have 
had a diabetes examination by a physician during the last 
year. 
If less strict endpoints of HbAic are used (8% or 9% 
instead of 7%), the proportion of diabetic older patients 
with poor glycemic control decreases considerably, and 
this change strengthens the argument that, among Costa 
Rican elderly, levels of metabolic control seem favorable. 
Elevated BP levels among elderly Costa Ricans with DM 
found in this study signals an important public health 
problem in the country. The combination of hypertension 
and DM yields very high total costs for the public health 
care services Ill. Further research is needed to learn the 
reasons for this poor hypertension control in Costa Rica, 
especially because there are no differences across health 
care settings. Preventive behaviors linked more strongly to 
hypertension than to DM or to dyslipidemias should be 
studied. Prevalence of high blood pressure in the general 
elderly Costa Rican population is extremely high: 64% 
among females and 55% among males [35]. DM patients 
do not escape to this pattern. Given that cardiovascular 
disease mortality is not high in this population, one won-
ders whether blood pressure distribution of other popula-
tions is applicable to Costa Rica [37]. High prevalence of 
elevated blood pressure persists even if cutoffs for defin-
ing elevated SBP and DBP are raised to 150 mmHg and 90 
mmHg respectively. 
Aside from hypertension, Costa Rican elderly with DM do 
not seem to perform worse at metabolic control than pop-
ulations in the industrialized world. Why are metabolic 
control levels so favorable among this population? One 
possible explanation is that Costa Ricans are commonly 
inclined to preventive health behaviors. Palmer [38] doc-
uments that Costa Rica was, in 1914, one of the few Latin 
American countries in which the goals of the Rockefeller 
Foundation anti-hookworm campaign were achieved. 
According to Palmer, the success of this campaign can be 
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explained by the active involvement of Government 
employees and rural teachers, and the willingness of the 
Costa Rican population to trust in these public workers. 
Regarding more recent data, with a non-representative 
sample of diabetic patients in San lose, Costa Rica's capi-
tal, Firestone et al. found that the levels of DM-specific 
knowledge were greater than in a sample of Spanish-
speaking U.S. Latinos in Starr County, Texas [39]. 
However, in general, achievements in health status in 
Costa Rica have been linked to effective primary health 
care services, provided mainly by public institutions and 
with a strong commitment with equity [12-14]. Although 
the Costa Rican government had a long tradition of pro-
viding those services (which was in part possible because 
of the non-existence of military expenditures since the 
1949 Constitution abolished the armed forces), in the 
1970s there was a breakthrough with the opening of hun-
dreds of Rural Health Posts [4]. More recently, a health 
sector reform launched in 1995 fostered the opening of 
community health centers or EBAIS to improve the access 
to primary health care services in underserved areas. It is 
hard to tell whether this "Costa Rican model" can be 
exported to other Latin American countries with much 
larger or less integrated populations, weaker institutions 
and fewer resources available for public health. 
These free primary health care services have been key 
mechanisms in the control of communicable diseases, 
maternal mortality, and children malnutrition. Nonethe-
less, the epidemiologic transition accompanied with the 
process of population aging [2,3] can bring changes that 
occur faster than the institutional ability to respond to 
them. This possible lag in institutional response may 
undermine the efficacy of this kind of services, especially 
in chronic disease management. 
The article's first goal-the assessment of metabolic control 
among the older population in Costa Rica-serves as an 
introduction for the second goal: to study whether meta-
bolic control among EBAIS patients is different than met-
abolic control among patients at other health care 
settings. The working hypothesis was that EBAIS older 
patients with DM had metabolic control levels equal or 
better than diabetic elderly patients at other clinical set-
tings because EBAIS are aimed to provide only primary 
health care services, and patients who need specialists are 
then referred to physicians at hospitals or dinics. The 
present article shows that, among the elderly population 
with DM in Costa Rica, there are no major differences in 
poor metabolic control between patients from public hos-
pitals and clinics on one side, and patients from commu-
nity health centers on the other. However, community 
health center patients are more likely to have elevated lev-
els of LDL and triglycerides. Since worse levels of meta- 
http://www.biomedeentralcom/1  472-698X18/5 
bolic control are not found for the other studied 
biomarkers (HbAic, HDL, SBP, and DBP), these results 
may mean that lipid control for elderly diabetic patients 
at community health care centers is not as thoroughly 
examined as at public hospitals and clinics, or at private 
clinical settings, perhaps because many EBAIS lack labora-
tory facilities. No differences in lipid-control medication 
intake or frequency of cholesterol examination were 
found across clinical settings; besides, differences in trig-
lycerides and LDL levels are not explained by differences 
in obesity or caloric intake, given that the multivariate 
models control for the effect of these variables. These dif-
ferences may also be related to particularities in DM edu-
cation at community health centers. 
It is important for the public health care system to address 
the high levels of blood pressure as well as the poorer lipid 
control among patients that go to EBAIS because these 
community health centers aim to improve the access to 
primary health care to underserved and poor populations, 
and primary health care is an effective way of managing 
chronic diseases such as DM by decreasing the need of sec-
ondary and tertiary health care services [40,41]. Even in 
industrialized countries such as the U.S.A., community 
health centers have been seen as an inexpensive way of 
providing preventive services to underserved and poor 
populations 131,42,431. However, in terms of DM con-
trol, community health centers in other countries have 
not always been successful [30,31,43]. 
The advanced stage of the epidemiological transition in 
Costa Rica is happening in the context of a health sector 
reform. The community health centers, a key component 
of the reform, are increasingly providing primary health 
care services to elderly patients with chronic disease. If the 
system of community health centers in Costa Rica turns to 
be successful in reducing the burden of both communica-
ble and chronic diseases, the Costa Rican health sector 
reform can serve as an experiment for other health sector 
reforms that international organisms are fostering in 
developing and transitional countries [45]. 
It is also worth noting that there are no differences in met-
abolic control between patients treated at public services 
and patients treated at private services, except in the fre-
quency of DM examination by physicians. Diabetic eld-
erly patients that visited a private outpatient service or that 
were treated at their own house are more likely to lack 
physician examination at least once a year. It is not clear 
whether this difference is due to financial barriers or med-
ical practices, but the results should call the attention to 
users and providers of private health care in Costa Rica. 
The analysis in this paper is performed using data from a 
nationally representative survey of elderly in Costa Rica 
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that gathers self-reported information, as well as biomar-
kers. This kind of dataset is rare in developing countries. 
However, there are limitations in the data. An important 
one is that the study relies on self-reported information 
which might be affected by reporting bias. Diabetic 
respondents in the survey were determined based on self-
reported answers to the question "Has a doctor or medical 
personnel ever told you that you have diabetes or high 
blood sugar levels?" This approach might overestimate 
the size of the actual diabetic population, and introduce 
biases in summarizing the outcome variables. If a physi-
cian ever told a person that she had impaired glucose tol-
erance or a one-time elevation in glucose, it is possible 
that this non-diabetic person will answer "yes" to the 
question in the survey instrument. We consider that it is 
inconvenient to validate the self-reported diagnosis with 
metabolic data because metabolic data is the outcome of 
this article. Therefore, any correction based on the 
biomarkers will bias upwards the prevalence of poor met-
abolic control. A way to explore the bias due to self-report 
is by using complementary information. The survey 
inquires about insulin use and other prescribed medica-
tion that respondents have in their house. Interviewers ask 
to see all prescribed drugs and enumerate them. Thirteen 
percent of the sample (weighted estimate) report not to be 
taking insulin or oral medication and also lack diabetes-
related medication in their houses. If excluding this 
group, results are roughly the same although the mean 
levels of the biomarkers and the prevalence of poor meta-
bolic control are slightly higher than with the original 
sample, but the differences are not statistically significant 
(a = 0.10). The most important differences between the 
two sets of results are that the difference in prevalence of 
LDL 	 100 mg/dl between community health center 
patients and patients at other health centers widens, espe-
cially among patients with statin medication, and that the 
percentage of elderly diabetic people without physician 
examination during the last 12 months drops from 10% 
to 4%. We decided not to exclude respondents without 
DM medication from the analyses because, even though 
some of them might be persons that do not have the dis-
ease, others might be diabetic patients that do not care 
about the treatment for their illness. Therefore, the analy-
sis would be based on a selected population of people that 
do care about controlling their disease. We do not report 
the results based on this subsample that excludes these 
potential non-diabetic respondents, but we can provide 
them upon request. 
The limitation due to self-reported data is also true for the 
main explanatory variable, place of last outpatient visit, as 
well as for most of the control variables. Reporting bias 
may arise from people that identify community health 
centers as clinics. Associated with this limitation, there is 
the problem that the survey questionnaire asks for the  
http://www.biomedcentral.com/1472-698X/8/5  
place of the last outpatient visit, but the questionnaire 
inquires neither whether the person visited another health 
care setting before the last outpatient visit, nor the reason 
of the last outpatient visit. It is possible that an undeter-
mined proportion of the diabetic older population that 
reported last outpatient visits might refer to consultations 
about health problems other than DM-related. We believe 
this lack of information would not introduce a strong bias 
in the estimates, insofar as physicians are supposed to be 
examining patients' DM control, regardless of the reason 
for the visit. However, this kind of bias can not be dis-
carded. 
Another data problem is its limited statistical power to 
detect some differences, because the sample size of all DM 
patients is just about 500. Given that the subsample size 
of EBAIS patients is around 180, and the levels of meta-
bolic control at the EBAIS range from 38% to 84% 
(depending on the indicator of metabolic control), the 
logistic regressions estimated for the final analyses have a 
statistical power of 0.80 to detect only odds ratios that are 
larger than 1.75 (or smaller than 0.55) for most of the 
biomarkers, and larger than 2.50 (or smaller than 0.30) 
for annual physician examination. Statistical power 
decreases even more when subsamples based on medica-
tion therapy are analyzed rather than the whole diabetic 
subsample. Power calculations are based on formulas for 
logistic regression analysis [46]. 
Conclusion 
Levels of metabolic control among elderly population 
with DM in Costa Rica are similar or better than levels 
observed in industrialized countries. Nevertheless, unusu-
ally high levels of BP indicate a problem in hypertension 
treatment among diabetic population age 60 years old. 
High BP levels are similar across health care settings. The 
study posed the hypothesis that poor metabolic control 
was less likely to occur among community health center 
patients than among patients from other clinical settings. 
Prevalence of elevated levels of SBP, DBP, and HbA1c is 
very similar across health care settings. Higher propor-
tions of people with elevated levels of triglycerides and 
LDL at community health centers may indicate problems 
of dyslipidemia treatment that are not observed in other 
health care settings. These higher proportions do not 
appear to be explained by differences in prescribed medi-
cation, frequency of lipid control by a physician, obesity, 
or caloric intake. The establishment of community health 
centers has been a key component of the health sector 
reform carried out since 1995 in Costa Rica. Eliminating 
these differences in metabolic control across health care 
settings is important for the health care system in the 
country because community health centers constitute a 
means of democratizing access to primary health care to 
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underserved and poor areas, and because DM produces 
high financial costs to the national health care system. 
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